美国胃癌筛查:当前证据、挑战与未来展望综述
本文综述全球胃癌流行病学、易感因素及筛查效力、获益风险与成本效果证据。亚洲内镜筛查可发现早期胃癌并降低死亡率,但美国缺乏高质量直接数据,需专门研究丰富美国一级和二级预防数据。
要点
- 美国非白人族裔和高发国家新移民胃癌发病与死亡率更高,部分与幽门螺杆菌相关癌前病变高患病率有关。
- 亚洲国家广泛证据显示内镜筛查可发现早期胃癌并降低胃癌相关死亡率。
- 美国缺乏大型临床试验或观察性研究的高质量直接数据来评估胃癌筛查重要结局。
核心结论
- 亚洲证据支持内镜筛查可发现早期胃癌并降低胃癌相关死亡率,但美国缺乏高质量直接数据。
- 亟需专门研究丰富美国胃癌一级和二级预防数据,以成本资源高效方式指导临床实践并降低胃癌相关发病和死亡。
研究设计与样本
- 综述:评估和总结全球关于胃癌流行病学、易感因素以及筛查效力、获益与风险、成本效果的最新证据。
主要发现
- 美国非白人族裔和高发国家新移民胃癌发病和死亡率显著更高,很大程度上与这些人群幽门螺杆菌相关胃癌癌前病变患病率更高有关。
- 亚洲国家广泛证据证明内镜筛查在发现早期胃癌和降低胃癌相关死亡率方面的获益。
- 美国仍缺乏关于胃癌筛查重要结局的直接高质量数据,如来自大型临床试验或观察性研究的数据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 美国仍缺乏关于胃癌筛查重要结局的直接高质量数据,如来自大型临床试验或观察性研究的数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gastric cancer remains a leading cause of cancer-related mortality worldwide. In the United States, gastric cancer incidence and mortality are substantially higher among non-White racial and ethnic groups and new immigrants from high-incidence countries. This is in large part related to the higher prevalence of Helicobacter pylori -associated gastric premalignant changes in these populations. Apart from primary prevention, early detection of gastric cancer is the principal strategy to reduce gastric cancer mortality and improve survival. Extensive evidence in Asian countries has demonstrated the benefits of endoscopic screening in detecting early-stage gastric cancer and reducing gastric cancer-related mortality. By contrast, direct, high-quality US-based data, such as from large clinical trials or observational studies, on important outcomes of gastric cancer screening are still lacking. In this review, we evaluate and summarize the latest global evidence on the epidemiology and predisposing factors of gastric cancer as well as the efficacy, benefits vs. risks, and cost-effectiveness of gastric cancer screening. We further discuss the critical knowledge gaps and challenges in promoting gastric cancer screening in the United States. Dedicated research is urgently needed to enrich the US-based data on gastric cancer primary and secondary prevention to inform clinical practice and reduce gastric cancer-related morbidity and mortality in a cost and resource efficient manner.
引用
- Li D, Morgan DR, Corral JE, et al. Gastric Cancer Screening in the United States: A Review of Current Evidence, Challenges, and Future Perspectives. Am J Gastroenterol. 2025. PMID: 40072512. doi:10.14309/ajg.0000000000003301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。